Skip to main content
Log in

Remissionsinduktion bei ANCA-assoziierten Vaskulitiden

Follow-up-Daten der RAVE-Studie

Remission induction in ANCA-associated vasculitis

Follow-up data of the RAVE study

  • Klinische Studien kurzgefasst
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Jones RB, Tervaert JW, Hauser T et al (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363(3):211–220

    Article  PubMed  CAS  Google Scholar 

  2. Stone JH, Merkel PA, Spiera R et al (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363(3):221–232

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  3. Walsh M, Merkel PA, Mahr A, Jayne D (2010) Effects of duration of glucocorticoidtherapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis. Arthritis Care Res (Hoboken) 62(8):1166–1173

    Article  Google Scholar 

Download references

Interessenkonflikt

B. Hellmich weist auf folgende Beziehungen hin: Vortragshonorare von und Beratungstätigkeit für Roche Pharma AG.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Hellmich.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hellmich, B. Remissionsinduktion bei ANCA-assoziierten Vaskulitiden. Z. Rheumatol. 73, 194–195 (2014). https://doi.org/10.1007/s00393-013-1292-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-013-1292-9

Navigation